Takeda's Pipeline Cleanup Leads to Layoffs and Program Cuts.
TL;DR Summary
Takeda is ending its seven-year partnership with Theravance and cutting a partnered Crohn's program after a Phase IIb failure. The company is also cutting seven clinical trials for various diseases and cancers and plans to lay off over 180 workers.
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
6 min
vs 7 min read
Condensed
97%
1,271 → 40 words
Want the full story? Read the original article
Read on Endpoints News